Research and Markets (http://www.researchandmarkets.com/research/5rg6hh/global_bipolar) has announced the addition of the "Global Bipolar Disorder Pipeline Capsule - 2013" report to their offering.
Fore Pharma's latest report "Global Bipolar Disorder Pipeline Capsule - 2013" provides up-to-date information on key Research and Development (R&D) activities in the global bipolar disorder market. It covers active bipolar disorder pipeline molecules in clinical trials, preclinical research, and drug discovery.
This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The scope of the report includes information on bipolar disorder pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Bipolar disorder pipeline molecules licensing activities are also covered in this report.
Key Features of the Report:
- Bipolar disorder Pipeline Overview
- Bipolar disorder Phase 3 Clinical Trial Pipeline
- Bipolar disorder Phase 2 Clinical Trial Pipeline
- Bipolar disorder Phase 1 Clinical Trial Pipeline
- Bipolar disorder Preclinical Research Pipeline
- Bipolar disorder Drug Discovery Stage Pipeline
- Bipolar disorder Pipeline in the U.S.
- Bipolar disorder Pipeline in Europe
- Licensing Activities in Global Bipolar Disorder Market
For more information visit http://www.researchandmarkets.com/research/5rg6hh/global_bipolar
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Bipolar Disorder